Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS
Condition(s):Gynecologic Cancer; Anemia, Iron Deficiency; SurgeryLast Updated:July 20, 2022Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Gynecologic Cancer; Anemia, Iron Deficiency; SurgeryLast Updated:July 20, 2022Not yet recruiting
Condition(s):Leukemia; Lymphoma; Multiple Myeloma; Blood Cancer; Stem Cell Transplant Complications; Chimeric Antigen Receptor T-cell TherapyLast Updated:March 2, 2023Recruiting
Condition(s):Lymphedema of Limb; Malignant Skin NeoplasmLast Updated:November 26, 2021Not yet recruiting
Condition(s):Trigeminal Autonomic CephalgiaLast Updated:July 21, 2023Recruiting
Condition(s):Chronic PainLast Updated:July 21, 2023Recruiting
Condition(s):Medication Adherence; Medication Compliance; Medication Nonadherence; Hypertension; Diabetes; Arthritis; Chronic Pain; Anxiety Depression; AsthmaLast Updated:October 20, 2020Completed
Condition(s):Septic ShockLast Updated:July 20, 2023Recruiting
Condition(s):DeliriumLast Updated:December 8, 2020Completed
Condition(s):Breast Cancer; Gynecologic CancerLast Updated:April 21, 2021Completed
Condition(s):Non-Hodgkin LymphomaLast Updated:January 10, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.